Your browser doesn't support javascript.
loading
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants.
Mühlemann, Barbara; Trimpert, Jakob; Walper, Felix; Schmidt, Marie L; Jansen, Jenny; Schroeder, Simon; Jeworowski, Lara M; Beheim-Schwarzbach, Jörn; Bleicker, Tobias; Niemeyer, Daniela; Richter, Anja; Adler, Julia M; Vidal, Ricardo Martin; Langner, Christine; Vladimirova, Daria; Wilks, Samuel H; Smith, Derek J; Voß, Mathias; Paltzow, Lea; Martínez Christophersen, Christina; Rose, Ruben; Krumbholz, Andi; Jones, Terry C; Corman, Victor M; Drosten, Christian.
Afiliação
  • Mühlemann B; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Trimpert J; German Centre for Infection Research (Deutsches Zentrum für Infektionsforschung), Berlin 10117, Germany.
  • Walper F; Institut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
  • Schmidt ML; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Jansen J; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Schroeder S; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Jeworowski LM; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Beheim-Schwarzbach J; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Bleicker T; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Niemeyer D; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Richter A; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Adler JM; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
  • Vidal RM; Institut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
  • Langner C; Institut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
  • Vladimirova D; Institut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
  • Wilks SH; Institut für Virologie, Freie Universität Berlin, Berlin 14163, Germany.
  • Smith DJ; Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, United Kingdom.
  • Voß M; Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, United Kingdom.
  • Paltzow L; Institute for Infection Medicine, Christian-Albrechts-Universität zu Kiel and University Medical Center Schleswig-Holstein, Kiel 24105, Germany.
  • Martínez Christophersen C; Labor Dr. Krause und Kollegen Medizinisches Versorgungszentrum GmbH, Kiel 24106, Germany.
  • Rose R; Labor Dr. Krause und Kollegen Medizinisches Versorgungszentrum GmbH, Kiel 24106, Germany.
  • Krumbholz A; Institute for Infection Medicine, Christian-Albrechts-Universität zu Kiel and University Medical Center Schleswig-Holstein, Kiel 24105, Germany.
  • Jones TC; Institute for Infection Medicine, Christian-Albrechts-Universität zu Kiel and University Medical Center Schleswig-Holstein, Kiel 24105, Germany.
  • Corman VM; Labor Dr. Krause und Kollegen Medizinisches Versorgungszentrum GmbH, Kiel 24106, Germany.
  • Drosten C; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
Proc Natl Acad Sci U S A ; 121(32): e2310917121, 2024 Aug 06.
Article em En | MEDLINE | ID: mdl-39078681
ABSTRACT
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) has developed substantial antigenic variability. As the majority of the population now has pre-existing immunity due to infection or vaccination, the use of experimentally generated animal immune sera can be valuable for measuring antigenic differences between virus variants. Here, we immunized Syrian hamsters by two successive infections with one of nine SARS-CoV-2 variants. Their sera were titrated against 16 SARS-CoV-2 variants, and the resulting titers were visualized using antigenic cartography. The antigenic map shows a condensed cluster containing all pre-Omicron variants (D614G, Alpha, Delta, Beta, Mu, and an engineered B.1+E484K variant) and considerably more diversity among a selected panel of Omicron subvariants (BA.1, BA.2, BA.4/BA.5, the BA.5 descendants BF.7 and BQ.1.18, the BA.2.75 descendant BN.1.3.1, the BA.2-derived recombinants XBB.2 and EG.5.1, and the BA.2.86 descendant JN.1). Some Omicron subvariants were as antigenically distinct from each other as the wildtype is from the Omicron BA.1 variant. Compared to titers measured in human sera, titers in hamster sera are of higher magnitude, show less fold change, and result in a more compact antigenic map topology. The results highlight the potential of sera from hamsters for the continued antigenic characterization of SARS-CoV-2.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Antigênica / Mesocricetus / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Antigênica / Mesocricetus / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2024 Tipo de documento: Article